| ICD-10-CM-2023 > D50-D89 > D70-D77 > D75 |
D70-D77 | Other disorders of blood and blood-forming organs | |
D75 | Other and unspecified diseases of blood and blood-forming organs | |
Excl2.: | acute lymphadenitis (L04.-) chronic lymphadenitis (I88.1) enlarged lymph nodes (R59.-) hypergammaglobulinemia NOS (D89.2) lymphadenitis NOS (I88.9) mesenteric lymphadenitis (acute) (chronic) (I88.0) | |
D75.0 | Familial erythrocytosis | |
Info: | Benign polycythemia Familial polycythemia | |
Excl1.: | hereditary ovalocytosis (D58.1) | |
D75.1 | Secondary polycythemia | |
Info: | Acquired polycythemia Emotional polycythemia Erythrocytosis NOS Hypoxemic polycythemia Nephrogenous polycythemia Polycythemia due to erythropoietin Polycythemia due to fall in plasma volume Polycythemia due to high altitude Polycythemia due to stress Polycythemia NOS Relative polycythemia | |
Excl1.: | polycythemia neonatorum (P61.1) polycythemia vera (D45) | |
D75.8 | Other specified diseases of blood and blood-forming organs | |
D75.81 | Myelofibrosis | |
Info: | Myelofibrosis NOS Secondary myelofibrosis NOS | |
Code first | the underlying disorder, such as: malignant neoplasm of breast (C50.-) | |
Use add'l | code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-) code for adverse effect, if applicable, to identify drug (T45.1X5) | |
Excl1.: | acute myelofibrosis (C94.4-) idiopathic myelofibrosis (D47.1) leukoerythroblastic anemia (D61.82) myelofibrosis with myeloid metaplasia (D47.4) myelophthisic anemia (D61.82) myelophthisis (D61.82) primary myelofibrosis (D47.1) | |
D75.82 | Heparin induced thrombocytopenia (HIT) | |
Use add'l | code, if applicable, for adverse effect of heparin (T45.515-) | |
D75.821 | Non-immune heparin-induced thrombocytopenia | |
Info: | Non-immune HIT Type 1 heparin-induced thrombocytopenia | |
D75.822 | Immune-mediated heparin-induced thrombocytopenia | |
Info: | Immune-mediated HIT Type 2 heparin-induced thrombocytopenia | |
D75.828 | Other heparin-induced thrombocytopenia syndrome | |
Info: | Autoimmune heparin-induced thrombocytopenia syndrome Delayed-onset heparin-induced thrombocytopenia Persisting heparin-induced thrombocytopenia | |
D75.829 | Heparin-induced thrombocytopenia, unspecified | |
D75.83 | Thrombocytosis | |
Excl2.: | essential thrombocythemia (D47.3) | |
D75.838 | Other thrombocytosis | |
Info: | Reactive thrombocytosis Secondary thrombocytosis | |
Use add'l | underlying condition, if known and applicable | |
D75.839 | Thrombocytosis, unspecified | |
Info: | Thrombocythemia NOS Thrombocytosis NOS | |
D75.84 | Other platelet-activating anti-PF4 disorders | |
Info: | Spontaneous heparin-induced thrombocytopenia syndrome (without heparin exposure) Thrombosis with thrombocytopenia syndrome Vaccine-induced thrombotic thrombocytopenia | |
Use add'l | code, if applicable, for adverse effect of other viral vaccine (T50.B95-) | |
D75.89 | Other specified diseases of blood and blood-forming organs | |
D75.9 | Disease of blood and blood-forming organs, unspecified | |
D75.A | Glucose-6-phosphate dehydrogenase (G6PD) deficiency without anemia | |
Excl1.: | glucose-6-phosphate dehydrogenase (G6PD) deficiency with anemia (D55.0) | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |